Chemical formula: C₁₄H₁₆N₄ Molecular mass: 240.304 g/mol PubChem compound: 57469
Imiquimod interacts in the following cases:
Due to its immunostimulating properties, imiquimod cream should be used with caution in patients who are receiving immunosuppressive medication.
For imiquimod no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Caution should be exercised when prescribing to pregnant women.
As no quantifiable levels (>5 ng/ml) of imiquimod are detected in the serum after single and multiple topical doses, no specific advice can be given on whether to use or not in lactating mothers.
Imiquimod cream has no or negligible influence on the ability to drive and use machines.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
